103 related articles for article (PubMed ID: 10071750)
1. Extracts and constituents of Hypericum perforatum inhibit the binding of various ligands to recombinant receptors expressed with the Semliki Forest virus system.
Simmen U; Burkard W; Berger K; Schaffner W; Lundstrom K
J Recept Signal Transduct Res; 1999; 19(1-4):59-74. PubMed ID: 10071750
[TBL] [Abstract][Full Text] [Related]
2. Hypericum perforatum inhibits the binding of mu- and kappa-opioid receptor expressed with the Semliki Forest virus system.
Simmen U; Schweitzer C; Burkard W; Schaffner W; Lundstrom K
Pharm Acta Helv; 1998 Jun; 73(1):53-6. PubMed ID: 9708037
[TBL] [Abstract][Full Text] [Related]
3. Interaction of various Piper methysticum cultivars with CNS receptors in vitro.
Dinh LD; Simmen U; Bueter KB; Bueter B; Lundstrom K; Schaffner W
Planta Med; 2001 Jun; 67(4):306-11. PubMed ID: 11458444
[TBL] [Abstract][Full Text] [Related]
4. In vitro binding studies with two hypericum perforatum extracts--hyperforin, hypericin and biapigenin--on 5-HT6, 5-HT7, GABA(A)/benzodiazepine, sigma, NPY-Y1/Y2 receptors and dopamine transporters.
Gobbi M; Moia M; Pirona L; Morizzoni P; Mennini T
Pharmacopsychiatry; 2001 Jul; 34 Suppl 1():S45-8. PubMed ID: 11518075
[TBL] [Abstract][Full Text] [Related]
5. In vitro receptor screening of pure constituents of St. John's wort reveals novel interactions with a number of GPCRs.
Butterweck V; Nahrstedt A; Evans J; Hufeisen S; Rauser L; Savage J; Popadak B; Ernsberger P; Roth BL
Psychopharmacology (Berl); 2002 Jul; 162(2):193-202. PubMed ID: 12110997
[TBL] [Abstract][Full Text] [Related]
6. Neurochemical studies with St. John's wort in vitro.
Simmen U; Higelin J; Berger-Büter K; Schaffner W; Lundstrom K
Pharmacopsychiatry; 2001 Jul; 34 Suppl 1():S137-42. PubMed ID: 11518063
[TBL] [Abstract][Full Text] [Related]
7. Preserved pharmacological activity of hepatocytes-treated extracts of valerian and St. John's wort.
Simmen U; Saladin C; Kaufmann P; Poddar M; Wallimann C; Schaffner W
Planta Med; 2005 Jul; 71(7):592-8. PubMed ID: 16041642
[TBL] [Abstract][Full Text] [Related]
8. Aqueous ethanolic extract of St. John's wort (Hypericum perforatum L.) induces growth inhibition and apoptosis in human malignant cells in vitro.
Hostanska K; Reichling J; Bommer S; Weber M; Saller R
Pharmazie; 2002 May; 57(5):323-31. PubMed ID: 12061257
[TBL] [Abstract][Full Text] [Related]
9. The lipophilic extract of Hypericum perforatum exerts significant cytotoxic activity against T24 and NBT-II urinary bladder tumor cells.
Skalkos D; Stavropoulos NE; Tsimaris I; Gioti E; Stalikas CD; Nseyo UO; Ioachim E; Agnantis NJ
Planta Med; 2005 Nov; 71(11):1030-5. PubMed ID: 16320204
[TBL] [Abstract][Full Text] [Related]
10. Mapping of dopamine D3 receptor binding site by pharmacological characterization of mutants expressed in CHO cells with the Semliki Forest virus system.
Lundstrom K; Turpin MP; Large C; Robertson G; Thomas P; Lewell XQ
J Recept Signal Transduct Res; 1998; 18(2-3):133-50. PubMed ID: 9651882
[TBL] [Abstract][Full Text] [Related]
11. High-level expression of G protein-coupled receptors with the aid of the Semliki Forest virus expression system.
Lundstrom K; Mills A; Allet E; Ceszkowski K; Agudo G; Chollet A; Liljestrom P
J Recept Signal Transduct Res; 1995; 15(1-4):23-32. PubMed ID: 8903928
[TBL] [Abstract][Full Text] [Related]
12. Determination of naphthodianthrones and phloroglucinols from Hypericum perforatum extracts by liquid chromatography/tandem mass spectrometry.
Tolonen A; Uusitalo J; Hohtola A; Jalonen J
Rapid Commun Mass Spectrom; 2002; 16(5):396-402. PubMed ID: 11857723
[TBL] [Abstract][Full Text] [Related]
13. Serotonin mediates beneficial effects of Hypericum perforatum on nicotine withdrawal signs.
Mannucci C; Pieratti A; Firenzuoli F; Caputi AP; Calapai G
Phytomedicine; 2007 Oct; 14(10):645-51. PubMed ID: 17689233
[TBL] [Abstract][Full Text] [Related]
14. Functional screening of traditional antidepressants with primary cortical neuronal networks grown on multielectrode neurochips.
Gramowski A; Jügelt K; Stüwe S; Schulze R; McGregor GP; Wartenberg-Demand A; Loock J; Schröder O; Weiss DG
Eur J Neurosci; 2006 Jul; 24(2):455-65. PubMed ID: 16903853
[TBL] [Abstract][Full Text] [Related]
15. Inhibition of benzodiazepine binding in vitro by amentoflavone, a constituent of various species of Hypericum.
Baureithel KH; Büter KB; Engesser A; Burkard W; Schaffner W
Pharm Acta Helv; 1997 Jun; 72(3):153-7. PubMed ID: 9204773
[TBL] [Abstract][Full Text] [Related]
16. Expression of ligand-gated ion channels with the Semliki Forest virus expression system.
Lundstrom K; Michel A; Blasey H; Bernard AR; Hovius R; Vogel H; Surprenant A
J Recept Signal Transduct Res; 1997; 17(1-3):115-26. PubMed ID: 9029484
[TBL] [Abstract][Full Text] [Related]
17. High performance liquid chromatography/electrospray mass spectrometry of Hypericum perforatum extracts.
Mauri P; Pietta P
Rapid Commun Mass Spectrom; 2000; 14(2):95-9. PubMed ID: 10623936
[TBL] [Abstract][Full Text] [Related]
18. Functional activity of a biotinylated human neurokinin 1 receptor fusion expressed in the Semliki Forest virus system.
Lundstrom K; Vargas A; Allet B
Biochem Biophys Res Commun; 1995 Mar; 208(1):260-6. PubMed ID: 7887938
[TBL] [Abstract][Full Text] [Related]
19. Biochemical and pharmacological characterization of the human bradykinin subtype 2 receptor produced in mammalian cells using the Semliki Forest virus system.
Shukla AK; Haase W; Reinhart C; Michel H
Biol Chem; 2006 May; 387(5):569-76. PubMed ID: 16740128
[TBL] [Abstract][Full Text] [Related]
20. St. John's wort extracts and some of their constituents potently inhibit ultimate carcinogen formation from benzo[a]pyrene-7,8-dihydrodiol by human CYP1A1.
Schwarz D; Kisselev P; Roots I
Cancer Res; 2003 Nov; 63(22):8062-8. PubMed ID: 14633740
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
